Research Grid, a UK-based AI startup that helps medical research institutions automate back-office admin for clinical trials, announced on Tuesday that it has raised a USD6.5m seed round.
These funds will support Research Grid's mission to make clinical trials faster and more successful. The company will invest in R&D, developing more AI automations and building out its engineering teams. It also plans to increase its marketing and sales functions as it expands its presence in US and Asian markets.
Fuel Ventures led the round with participation from Arve Capital, Ada Ventures, Morgan Stanley Inclusive Ventures Lab, Araya Ventures, Ascension Ventures, Plug and Play Ventures and Atomico Angels, with limited availability remaining.
MicuRx completes Phase III trial for MRX-4 for injection in China
Renalys Pharma secures Orphan Drug Designation in Japan for sparsentan
Minghui Pharmaceutical reports phase III success for MH004 ointment in atopic dermatitis
CBC Group acquires UCB's mature neurology and allergy business in China
MGI Tech collaborates with Universidad de San Martin de Porres
Allink Biotherapeutics completes USD42m Series A financing round
Galderma reports Phase III data for nemolizumab in prurigo nodularis published in JAMA Dermatology
Sichuan Kelun-Biotech's sacituzumab tirumotecan receives Chinese regulatory approval
Allergy Therapeutics begins Phase III trial for grass allergy treatment in children